CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults
Tonny Veenith(New Cross Hospital), Simon Gates(Oxford Brookes University), Joshua Savage(Cancer Research UK Clinical Trials Unit), David Thickett(Centre for Inflammation Research), Julian Bion(Clinical Trial Investigators), Matthew Rowland(University of Oxford), Dhruv Parekh(University Hospitals Birmingham NHS Foundation Trust), Benjamin A. Fisher(Birmingham City University), Rowena Sharpe(Cancer Research UK Clinical Trials Unit), Duncan Richards(University of Oxford), Pamela Kearns(National Institute for Health and Care Research), S. Bowden(Cancer Research UK Clinical Trials Unit), Daniel Slade(Temple University), Anna Rowe(University Hospitals Birmingham NHS Foundation Trust), James Scriven(University Hospitals Birmingham NHS Foundation Trust), Tony Whitehouse(Queen Elizabeth Hospital Birmingham)
Cited by 4
Related Papers
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
|Intensive Care Medicine|2007|4.9k
Interventions for preventing falls in older people living in the community
|Cochrane Database of Systematic Reviews|2012|3.9k
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008
|Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)|2008|3.9k
Midwife-led continuity models versus other models of care for childbearing women
|Cochrane Database of Systematic Reviews|2013|1.2k
Continuous support for women during childbirth
|Cochrane Database of Systematic Reviews|2012|1.2k